Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ustekinumab for moderate to severe plaque psoriasis with inadequate response to prior biologics
ChiCTR2500111403Phase 4Not yet recruiting
- Sponsor
- Southern Medical University Dermatology Hospital
- Start
- Oct 2025
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ustekinumab in plaque psoriasis, sponsored by Southern Medical University Dermatology Hospital. Primary endpoint: PASI 75 at week 16. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
ustekinumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on ChiCTR2500111403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500111403.